# MiNK Therapeutics, Inc.: Form 8-K, filed Feb 14, 2024

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2024-02-14
- Accepted by EDGAR: Feb 14, 2024, 13:00 ET
- Period: 2024-02-12
- Accession: 0000950170-24-014944
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000095017024014944/inkt-20240212.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000095017024014944/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000095017024014944/inkt-20240212.htm

Filed Feb 14, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-014944. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.